FDA Clearance Tracker · K203490
FORE-SIGHT ELITE Absolute Tissue Oximeter
Last checked: Nov 20, 2026Latest source record: Feb 10, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Feb 10, 2021
Substantially Equivalent
Time to decision
75 days
Received Nov 27, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K203490
- Device name
- FORE-SIGHT ELITE Absolute Tissue Oximeter
- Applicant
- Edwards Lifesciences, LLC
- Applicant location
- Irvine, CA
- Received
- Nov 27, 2020
- Decided
- Feb 10, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Oximeter, Tissue Saturation (MUD)
- Device class
- Class II
- Regulation
- 21 CFR 870.2700
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MUD. The earliest in FDA's data is K963903, decided Jan 27, 1998.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K203490
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Edwards Lifesciences, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PASCAL Precision Transcatheter Valve Repair SystemPMA supplement
P220003-S029 · Decided Oct 20, 2026 · 180 days after receipt · Panel Track
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
P260007 · Decided Oct 1, 2026 · 234 days after receipt
Device type: Heart-valve, polymeric (SJL) · Cardiology
K251326 · Decided Jun 11, 2026 · 408 days after receipt
Device type: Monitor, Breathing Frequency (BZQ) · Anesthesiology & Respiratory
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.